Abstract
The authors regret the omission of funding information for grant number 2023R1A2C3004010 in the Acknowledgments section of the original publication. The authors would like to amend the Acknowledgments as follows: “This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute ( KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant numbers: HA17C0053, HR20C0021), and by the National Research Foundation ( NRF) of Korea, funded by the Korean government (MSIT) (grant numbers: 2022R1A2C2004933, 2023R1A2C3004010)." The authors would like to apologise for any inconvenience caused.
| Original language | English |
|---|---|
| Article number | 117194 |
| Journal | European Journal of Medicinal Chemistry |
| Volume | 283 |
| DOIs |
|
| State | Published - 5 Feb 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Corrigendum to “Discovery of indazole inhibitors for heat shock protein 90 as anti-cancer agents” [Eur. J. Med. Chem. (2024) 116620](S0223523424005002)(10.1016/j.ejmech.2024.116620)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver